Arca biopharma announces c. jeff dekker to be appointed chief financial officer

Westminster, colo., may 03, 2021 (globe newswire) -- arca biopharma, inc. (nasdaq: abio), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced c. jeff dekker as its chief financial officer, effective may 10, 2021, following brian selby's planned departure after 14 years of service with the company.
ABIO Ratings Summary
ABIO Quant Ranking